Private Advisor Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,355
Closed -$333K 2014
2022
Q3
$333K Buy
+1,355
New +$366K ﹤0.01% 1423
2022
Q2
Sell
-757
Closed -$251K 2287
2022
Q1
$251K Buy
757
+3
+0.4% +$923 ﹤0.01% 1774
2021
Q4
$271K Buy
754
+22
+3% +$7.43K ﹤0.01% 1781
2021
Q3
$238K Buy
732
+5
+0.7% +$1.69K ﹤0.01% 1806
2021
Q2
$227K Hold
727
﹤0.01% 1767
2021
Q1
$232K Sell
727
-20
-3% -$6.4K ﹤0.01% 1670
2020
Q4
$242K Sell
747
-3,844
-84% -$1.06M ﹤0.01% 1556
2020
Q3
$1.27M Buy
4,591
+3,774
+462% +$1.09M 0.02% 697
2020
Q2
$197K Sell
817
-1,411
-63% -$283K ﹤0.01% 1374
2020
Q1
$323K Buy
+2,228
New +$370K 0.01% 1042
2018
Q3
Sell
-3,700
Closed -$1.51M 1669
2018
Q2
$1.51M Buy
+3,700
New +$1.34M 0.02% 364

Other funds holding ABMD

Private Advisor Group's ABMD Position: Q4 2022 in Review

Private Advisor Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,355 shares — an estimated $333K sold.

Private Advisor Group first reported a position in ABMD in Q2 2018 and held it in 11 quarters. The position peaked at $1.51M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Private Advisor Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 1,355 Abiomed Inc shares in Q4 2022, an estimated $333K.
  • Private Advisor Group first reported a position in Abiomed Inc in Q2 2018 and held it in 11 quarters.
  • Private Advisor Group's Abiomed Inc position peaked at $1.51M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.